Cookies on this site

Drinking tea and coffee at a very hot temperature, rather than warm, is linked to a threefold increase in the risk of oesophageal squamous cell carcinoma, according to a new study co-authored by Clinical Research Training Fellowship programme alumna, Kezia Gaitskell.

Squamous cell carcinoma (SCC) is one of the two main types of oesophageal cancer. The risk of being diagnosed with SCC remains relatively low in the UK: it is the 14th most common cancer, accounting for 2% of all new cancer cases. 

Drinking very hot beverages, such as mate, has previously been linked to a higher risk of this cancer in studies from South America, Asia, the Middle East and Africa, where such drinks are more commonly consumed at very high temperatures. Until now, there has been little large-scale evidence on the degree to which differences in the temperature at which people in Western populations drink tea and coffee, the most commonly consumed hot drinks in the UK, might also affect risk. In a 2016 evaluation, the World Health Organization’s International Agency for Research on Cancer defined ‘very hot’ drinks as being above 65 degrees Celsius.  

To investigate this, the research team combined data from two large UK cohorts, UK Biobank and the Million Women Study, covering around 980,000 adults in total. Participants self-reported how hot they usually liked their tea and coffee (very hot, hot, warm, or that they did not drink hot drinks) and how many cups they drank a day, and were then followed through NHS records for an average of 14.1 years (Million Women Study) and 11.1 years (UK Biobank). This makes it the largest study of oesophageal cancer conducted to date. 

People who reported usually drinking their tea and coffee very hot, rather than warm, were found to have a threefold increase in the risk of oesophageal SCC.

The study, co-authored by Dr Gaitskell and fellow researchers at Oxford Population Health’s Cancer Epidemiology Unit, is published in International Journal of Cancer.  Read the full story on the Oxford Population Health Website.

Oxford Cancer’s DPhil in Cancer Science

Dr Kezia Gaitskell undertook her DPhil in the Clinical Epidemiology Unit at Oxford Population Health as part of our Cancer Research UK Oxford Centre’s Clinical Research Training Fellowship programme

Rebranded as the DPhil in Cancer Science in 2020, the programme now provides research-based doctoral training for cancer researchers from clinical, biological, engineering, mathematics and statistics backgrounds. 

During her DPhil, Dr Gaitskell researched risk factors for ovarian cancer using data from the Million Women Study. Her research showed that associations between certain risk factors and ovarian cancer vary between different types of ovarian cancer, helping to inform understanding of how these subtypes may develop.

Since completing her DPhil in 2017, Dr Gaitskell has continued to develop her research career as a clinical academic, including studying the causes and risk factors for ovarian and kidney cancer, as well as SCC.

Visit our study pages to find out more about the DPhil in Cancer Science.

Similar stories

Celebrating student research at Oxford Cancer's DPhil in Cancer Science Symposium 2026

On 20 October, Oxford Cancer welcomed students to St Anne’s College for its annual Student Symposium, with this year’s theme focusing on Cancer Research in the Age of Artificial Intelligence.

Experts gather for the second annual Oxford Oesophagogastric Cancer Centre of Excellence Symposium

Our second annual Oxford Oesophagogastric Cancer Centre of Excellence Symposium took place on Friday 6 March, bringing together researchers and clinicians from across Oxford alongside external collaborators for a stimulating day of multidisciplinary discussion.

New research reveals why some oesophageal cancers are so hard to treat

Research published today in Science Advances has uncovered new insights into why the most aggressive oesophageal cancers are so difficult to treat and how the body’s own defence systems are helping them to thrive.